By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708



Company News
Shire (SHPG) Announces Winners Of Spotlight On Gaucher Film Contest To Mark International Gaucher Day 10/1/2015 10:13:41 AM
Shire (SHPG) To Participate At The Leerink Partners 4th Annual Rare Disease Roundtable 9/30/2015 7:56:39 AM
Shire (SHPG) Receives European Approval For INTUNIV (Guanfacine) Hydrochloride Prolonged Release Tablets) As A Non-Stimulant ADHD Treatment For Children And Adolescents 9/21/2015 9:57:11 AM
Shire (SHPG) To Participate At Two Upcoming Investor Conferences 9/14/2015 11:45:14 AM
Shire (SHPG) Mulls Ways to Sweeten Bid for Baxalta, Getting Cash to Baxalta Shareholders Faster 9/14/2015 8:38:10 AM
Shire (SHPG)’s Plan B if Baxalta Bid Falls Through Includes Radius Health (RDUS), Actelion (ALIOF.PK), and Possibly Ariad (ARIA) 9/8/2015 6:07:42 AM
Sangamo BioSciences (SGMO) And Shire (SHPG) Restructure Collaboration To Accelerate Development Of ZFP Therapeutics For The Treatment Of Hemophilia And Huntington's Disease 9/2/2015 6:48:18 AM
Shire (SHPG) Appoints Sara Mathew To Board Of Directors 9/1/2015 6:36:48 AM
Shire (SHPG) To Attain Enhanced CINRYZE Manufacturing Flexibility And Capacity 8/25/2015 8:36:35 AM
Shire (SHPG) and Baxalta Maneuver To Sweeten Bid Or Shut It Down 8/14/2015 6:02:39 AM